Search hospitals > Maryland > Baltimore
University of Maryland
Claim this profileBaltimore, Maryland 21201
Global Leader in Heart Failure
Global Leader in High Blood Pressure
Conducts research for Human Immunodeficiency Virus Infection
Conducts research for Stroke
Conducts research for Infections
618 reported clinical trials
118 medical researchers
Summary
University of Maryland is a medical facility located in Baltimore, Maryland. This center is recognized for care of Heart Failure, High Blood Pressure, Human Immunodeficiency Virus Infection, Stroke, Infections and other specialties. University of Maryland is involved with conducting 618 clinical trials across 1,009 conditions. There are 118 research doctors associated with this hospital, such as Hyun Kim, Ranee Mehra, MD, Mark Mishra, MD, and Bradley Taylor, M.D.Top PIs
Hyun KimWashington University School of Medicine3 years of reported clinical research
Studies Pulmonary Fibrosis
Studies Fibrosis
30 reported clinical trials
42 drugs studied
Ranee Mehra, MDUniversity of Maryland/Greenebaum Cancer Center5 years of reported clinical research
Expert in Cancer
Expert in Squamous Cell Carcinoma
21 reported clinical trials
54 drugs studied
Mark Mishra, MDUniversity of Maryland/Greenebaum Cancer Center2 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
19 reported clinical trials
43 drugs studied
Bradley Taylor, M.DUniversity of Maryland Medical Center3 years of reported clinical research
Studies Aortic Aneurysm
Studies Thoracic Aortic Aneurysm
10 reported clinical trials
13 drugs studied
Clinical Trials running at University of Maryland
Non-Hodgkin's Lymphoma
Prostate Cancer
Multiple Myeloma
Stroke
Migraine
Lymphoma
Schizophrenia
Plasma Cell Neoplasms
Bleeding
Non-Small Cell Lung Cancer
Epcoritamab + R-CHOP
for Diffuse Large B-Cell Lymphoma
This trial tests a new drug called epcoritamab combined with a mix of cancer-fighting drugs in adults with a rare type of aggressive cancer called DLBCL. Epcoritamab helps the immune system attack cancer cells, while the other drugs work together to kill them. This combination has been used as the standard treatment for patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) for many years.
Recruiting2 awards Phase 3
IKS03
for B-Cell Lymphoma
This first-in-human study will evaluate the recommended dose for further clinical development, safety, tolerability, antineoplastic activity, immunogenicity, pharmacokinetics and pharmacodynamics of IKS03, a CD19 targeting antibody-drug conjugate, in patients with advanced B cell non-Hodgkin lymphoma (NHL).
Recruiting1 award Phase 1
Epcoritamab Combo
for Non-Hodgkin's Lymphoma
This trial tests a new drug called epcoritamab, given with other cancer drugs, to treat adults with Non-Hodgkin lymphoma. The study aims to see if this combination is safe and effective. Participants will have periodic health evaluations to monitor their health and the treatment's impact.
Recruiting1 award Phase 210 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Maryland?
University of Maryland is a medical facility located in Baltimore, Maryland. This center is recognized for care of Heart Failure, High Blood Pressure, Human Immunodeficiency Virus Infection, Stroke, Infections and other specialties. University of Maryland is involved with conducting 618 clinical trials across 1,009 conditions. There are 118 research doctors associated with this hospital, such as Hyun Kim, Ranee Mehra, MD, Mark Mishra, MD, and Bradley Taylor, M.D.
Where is University of Maryland located?
**Directions to University of Maryland Medical Center, Baltimore:**
- From I-95 North, take Rt. 395 towards downtown Baltimore.
- Exit onto Martin Luther King, Jr., Blvd., and turn right at the fourth traffic light onto Baltimore St.
- Turn left at the second traffic light onto Paca St. Visitor parking is available immediately on the right at the Baltimore Grand Garage.
Who should I call to ask about financial aid or insurance network?
For hospital billing inquiries, reach out to the University of Maryland Medical System Patient Financial Services Office at 410-821-4140. For questions regarding physician services billing, dial 410-528-5710. For financial assistance or inquiries about reduced-cost medically necessary care, contact 410-528-5710 or 888-243-8890. University students seeking financial assistance should call 410-706-7347.
What insurance does University of Maryland accept?
The University of Maryland offers comprehensive insurance coverage across its facilities:
- The Faculty Practice at the University of Maryland, Baltimore, accepts many dental insurance companies, including United Concordia PPO, but not United Concordia DHMO or any HMO plans.
- The University of Maryland Baltimore Washington Medical Center and the University of Maryland Medical Center accept a wide range of insurance providers, including Aetna, Amerigroup, Blue Cross Blue Shield, and many managed care plans. Services at UM Children's Hospital and UM Greenebaum Comprehensive Cancer Center are covered.
- The University Health Center, serving students, faculty, and staff, is in network with Aetna, Blue Cross Blue Shield, Carefirst, United Health Care, Cigna, and Maryland Medicaid, but cannot file claims with Medicare, Kaiser Permanente, Out of State Medicaid, and some HMO plans.
Patients are advised to verify their insurance coverage and any necessary authorizations or referrals before scheduling appointments.
What awards or recognition has University of Maryland received?
The University of Maryland Medical Center in Baltimore, Maryland, is renowned for its specialty care in Ear, Nose & Throat and Pediatric Cardiology & Heart Surgery, earning a spot in the U.S. News & World Report Best Hospital rankings for five consecutive years. It has also been awarded the American Heart Association/American Stroke Association’s Get With The Guidelines® Target: Stroke Honor Roll Elite Plus Gold Plus Quality Achievement Award. This accolade highlights the center's dedication to delivering stroke patients with treatment that adheres to nationally recognized guidelines.